Manikay Partners’s Bausch Health BHC Stock Holding History

Manikay Partners’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-700,000	Closed	-$10.2M	–	30
2016 Q4	$10.2M	Buy	+700,000	New	+$12.8M	0.54%	29

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Manikay Partners's BHC Position: Q1 2017 in Review

Manikay Partners sold out of Bausch Health (BHC) in Q1 2017, closing a stake of 700,000 shares — an estimated $10.2M sold.

Manikay Partners first reported a position in BHC in Q4 2016 and held it in 1 quarter. The position peaked at $10.2M in Q4 2016. 327 funds tracked by Wall St. Rank hold BHC as of Q1 2017.

Manikay Partners reported no remaining Bausch Health position as of Q1 2017 after selling out during the quarter.
Manikay Partners sold 700,000 Bausch Health shares in Q1 2017, an estimated $10.2M.
Manikay Partners first reported a position in Bausch Health in Q4 2016 and held it in 1 quarter.
Manikay Partners's Bausch Health position peaked at $10.2M in Q4 2016.
327 funds tracked by Wall St. Rank held Bausch Health as of Q1 2017.

Based on Manikay Partners's 13F filing for Q1 2017, filed 15 May 2017.